Welcome to our dedicated page for Blackbaud SEC filings (Ticker: BLKB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Revenue recognition rules, deferred revenue balances and donor-database churn make Blackbaud’s filings a tough read. If you have ever asked “Where can I find Blackbaud’s quarterly earnings report 10-Q filing?� or searched for “Blackbaud insider trading Form 4 transactions,� you already know the challenge.
Stock Titan solves it. Our AI parses every 10-K, 10-Q, 8-K and proxy within seconds, delivering plain-English briefs that turn legal jargon into actionable insight. Whether you need “Blackbaud annual report 10-K simplified,� “Blackbaud proxy statement executive compensation� details, or a quick alert on “Blackbaud Form 4 insider transactions real-time,� you will find the answer here. The platform updates the moment a document hits EDGAR, so “Blackbaud 8-K material events explained� really means explained immediately.
- Track “Blackbaud executive stock transactions Form 4� to spot buying or selling trends before grantmaking announcements.
- Compare fundraising software segment margins with our “Blackbaud earnings report filing analysis.�
- Use AI-generated highlights for understanding Blackbaud SEC documents with AI—no more skimming 250 pages for one metric.
- Set alerts for subscription metrics hidden in each “Blackbaud quarterly earnings report 10-Q filing.�
All filings, all forms, real-time—Blackbaud SEC filings explained simply so you can focus on decision-making, not document mining.
Director Deneen DeFiore reported a sale of 4,000 shares of Blackbaud, Inc. (BLKB) on 08/29/2025 at a price of $66.6114 per share, reducing her direct holdings to 10,069 shares. The Form 4 was signed by an attorney-in-fact on 09/03/2025. The filing discloses the transaction details required under Section 16 and shows the director disposed of roughly 28.4% of her previously held shares.
Blackbaud, Inc. (BLKB) Form 144 notice: An officer or other person affiliated with the company reported a proposed sale of 4,000 common shares through Merrill Lynch, valued at $266,445.60, with an approximate sale date of 08/29/2025 on NASDAQ. The shares were acquired on 08/01/2023 via vesting of a stock award from Blackbaud, Inc., and the acquisition was compensatory in nature. The filer reports 48,509,032 shares outstanding, so the proposed sale represents a very small fraction of total shares outstanding. No sales by the filer in the past three months were reported. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Rupal S. Hollenbeck, a director of Blackbaud Inc. (BLKB), reported a direct sale of 2,500 common shares on 08/08/2025 at $63.98 per share. After the disposition, the report shows she beneficially owns 7,966 shares directly. The filing records a straightforward, non-derivative disposition reported on Form 4, indicating a routine insider sale rather than any options or complex securities activity.
Blackbaud, Inc. (BLKB) filed a Form 144 reporting a proposed sale of 2,500 common shares to be executed through Merrill Lynch on the NASDAQ with an aggregate market value of $159,950. The securities were acquired on 08/01/2025 upon the vesting of a stock award from Blackbaud, Inc., and the transaction is described as a compensatory payment. The approximate date of sale is listed as 08/08/2025. The filing also discloses there were no securities sold by the same person in the prior three months and includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
Blackbaud, Inc. (BLKB) director Kristian Talvitie has filed a Form 4 disclosing receipt of 3,670 shares of company common stock on 1 Aug 2025. The shares were granted as a restricted stock award with no purchase price. They will vest in full on 1 Aug 2026 or, if earlier, immediately before the company’s 2026 annual director election, provided Talvitie continues to serve on the board.
Following the grant, Talvitie’s directly held stake increases to 8,053 shares. No derivative securities were reported and there were no sales or dispositions. Because this is a routine, compensation-related award rather than an open-market purchase, the filing has limited signalling impact for investors, though it modestly raises insider alignment.
On 08/01/2025, Blackbaud, Inc. (BLKB) director Bradley L. Pyburn disclosed the award of 3,670 restricted shares of common stock at no cost (Form 4 transaction code “A�) in a filing dated 08/05/2025. Following the grant, Pyburn’s direct ownership rises to 5,269 shares.
The award will vest on 08/01/2026, or immediately before Blackbaud’s 2026 annual director election if earlier, provided he remains a director. No derivative positions or dispositions were reported, indicating a routine equity-based board compensation event with negligible dilution.
FAQ
What is the current stock price of Blackbaud (BLKB)?
What is the market cap of Blackbaud (BLKB)?
